$4.60
-0.12-2.54%
Dern. MÀJ: Oct 23, 5:23 PM
Kyntra Bio (KYNB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-3.18 | — | $-3.89 | $-4.01 |
| Actual | $-4.68 | $-3.74 | $-3.61 | $-3.25 |
| Surprise | -47.2% | — | +7.20% | +18.9% |
| Revenue | ||||
| Estimate | $2.0M | — | $1.6M | $1.6M |
| Actual | $-1.5M | $3.7M | $1.3M | $1.1M |
| Surprise | -173.6% | — | -20.8% | -34.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-3.40 | $-3.55 | $-2.87 | $-3.08 |
| Revenue | ||||
| Consensus | $1.8M | $2.3M | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-4.68 | $-3.18 | -47.2 % |
| Q4 | Mar 16, 2026 | $-3.61 | $-3.89 | 7.20 % |
| Q3 | Nov 10, 2025 | $-3.25 | $-4.01 | 18.9 % |
| Q2 | Aug 11, 2025 | $-1.88 | $-0.30 | -526.7 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-1.47M | $2.00M | -173.6 % |
| Q4 | Mar 16, 2026 | $1.30M | $1.64M | -20.8 % |
| Q3 | Nov 10, 2025 | $1.08M | $1.64M | -34.4 % |
| Q2 | Aug 11, 2025 | $1.35M | $2.89M | -53.3 % |